01Core principlesThe concepts and mechanisms needed to understand the subject.
Contrast-associated acute kidney injury describes a temporal association after contrast, whereas contrast-induced injury implies causation. Illness severity, sepsis, hypotension and other nephrotoxins confound many observed creatinine rises, so risk should be managed without overstating certainty.
Elective assessment identifies current acute kidney injury, renal disease, previous renal surgery, diabetes, proteinuria and other reasons to obtain eGFR. The greatest routine intravenous concern is severe renal impairment, especially eGFR below 30 mL/min/1.73 m².
Hypersensitivity can be immediate, usually within one hour but occasionally later, or non-immediate over subsequent days. The record must describe the clinical phenotype and exact product rather than leave an unhelpful generic allergy label.
Key points
- Do not delay emergency contrast CT that is required to prevent loss of life, limb, or immediate definitive therapy while waiting for renal tests.
- For routine intravenous contrast, acute kidney injury or eGFR below 30 mL/min/1.73 m² triggers individual risk-benefit review and preventive planning.
- A previous reaction to the specific contrast agent is the key hypersensitivity history; identify agent, timing, features, severity and treatment.
- Use low- or iso-osmolar iodinated contrast at the lowest dose that still answers the question, and avoid unsupported under-dosing.
- With eGFR above 30 and no acute kidney injury, metformin can usually continue for intravenous or second-pass intra-arterial contrast.
- If eGFR is below 30, acute kidney injury is present, or first-pass renal arterial exposure is used, stop metformin at administration and recheck renal function within forty-eight hours before restart if stable.
02Mechanisms and patternsImportant relationships and how to distinguish them.
A creatinine rise follows exposure in time but may arise from concurrent illness; temporal association alone does not prove contrast causation.
Current acute kidney injury, eGFR below 30 for intravenous contrast, unstable physiology or relevant arterial administration warrants focused review.
Urticaria, angioedema, bronchospasm, hypotension or anaphylaxis begins within an hour in most cases and needs severity-based treatment.
A delayed eruption can emerge hours to days later; severe cutaneous or systemic features need urgent assessment and documentation.
Record generic name, brand where available, dose, route, timing, symptoms, severity and treatment to guide future selection.
Metformin itself does not increase contrast kidney injury, but accumulation during significant acute renal deterioration can contribute to lactic acidosis.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Current creatinine and eGFR - Why
- Stratify renal risk for non-emergency intravascular contrast.
- Interpretation and limitations
- Use a suitably recent result matched to clinical stability; acute kidney injury cannot be excluded by a single reassuring eGFR.
- 02
Acute kidney injury assessment - Why
- Identify dynamic renal deterioration and reversible contributors.
- Interpretation and limitations
- Review creatinine trend, urine output, haemodynamics, sepsis, obstruction and nephrotoxins rather than relying on one value.
- 03
Contrast reaction history - Why
- Define agent-specific hypersensitivity risk and phenotype.
- Interpretation and limitations
- The exact prior agent and reaction severity are more useful than a vague label; obtain old imaging and anaesthetic records where possible.
- 04
Allergy specialist assessment - Why
- Evaluate moderate, severe, recurrent or multi-agent reactions.
- Interpretation and limitations
- Testing and structured documentation can identify safer alternatives; it does not justify unplanned re-exposure to the culprit.
- 05
Post-contrast renal function - Why
- Detect deterioration in patients judged at risk.
- Interpretation and limitations
- ESUR advises eGFR assessment around forty-eight hours after exposure in at-risk patients, with longer follow-up if injury is present.
- 06
Serum tryptase - Why
- Support assessment after a moderate or severe immediate reaction.
- Interpretation and limitations
- Obtain according to the acute reaction pathway and allergy guidance; a result never replaces immediate clinical treatment.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked caseEmergency bleeding with unknown renal functionAn unstable patient needs enhanced CT to direct immediate haemorrhage control.+
- 1Context: confirm that delay threatens life, limb or access to definitive treatment and continue simultaneous resuscitation.
- 2Reasoning: recognise that renal blood testing, diabetes, metformin use or fluid preparation must not postpone the emergency scan.
- 3Outcome: perform the necessary diagnostic contrast examination with an appropriate low- or iso-osmolar agent and no avoidable phases.
- 4Verification: document the emergency justification, review renal function and urine output afterwards, and manage any deterioration clinically.
02Elective renal routeReduce kidney riskA stable patient with acute kidney injury or eGFR below 30 is proposed for intravenous contrast.+
- 1Clarify the clinical value, urgency, alternative imaging and whether unenhanced imaging would answer the question.
- 2Discuss with radiology, correct dehydration or haemodynamic problems, and use intravenous volume expansion where appropriate.
- 3Use low- or iso-osmolar contrast and the lowest diagnostically adequate dose while avoiding repeat exposure where feasible.
- 4Arrange renal review at about forty-eight hours and continue follow-up if acute kidney injury develops.
03Reaction preventionPlan after prior hypersensitivityPrevious immediate or clinically important delayed reaction is reported before a planned study.+
- 1Retrieve the agent, timing, symptoms, severity and treatment; correct nonspecific records where evidence permits.
- 2Consider an adequate non-contrast examination or another modality before deciding contrast is essential.
- 3Use specialist allergy and radiology advice, avoid the culprit where possible, and select an alternative agent.
- 4Perform the study where trained staff, observation and resuscitation equipment are immediately available.
04Acute reactionTreat and document hypersensitivityNew allergic-like symptoms occur during or after iodinated contrast administration.+
- 1Stop administration, assess airway, breathing and circulation, call for help and follow the emergency reaction algorithm.
- 2Treat anaphylaxis immediately according to the current resuscitation protocol without waiting for laboratory confirmation.
- 3Observe according to severity, arrange admission for severe reactions and provide delayed-reaction safety-net advice.
- 4Record exact contrast product, dose, route, timing, phenotype, severity, treatment and future referral plan.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Review renal function and clinical fluid status after contrast in patients classified as high risk.
- Record whether metformin was continued, paused and safely restarted according to renal status and exposure route.
- Observe immediate reactions for recurrence according to severity and arrange admission after severe events.
- Provide written safety-net advice for delayed rash, mucosal lesions, blistering, fever or systemic symptoms.
- Update the allergy record with the exact agent and reaction phenotype, and confirm specialist referral for qualifying reactions.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Association is not causation
Creatinine often rises in acutely ill patients without contrast; use the CA-AKI term unless a causal assessment supports contrast-induced injury.
Emergency boundary is narrow
The no-delay rule applies when postponement threatens life, limb or immediate definitive therapy; routine and elective imaging still require normal risk assessment.
Hydration is selective
Volume expansion is considered for patients at renal risk after checking cardiac and fluid status; forced oral intake is not a substitute for clinical judgement.
No universal prophylactic drug
Current ESUR guidance finds no pharmacological prophylaxis consistently protective against post-contrast acute kidney injury.
Premedication varies
Premedication evidence and protocols vary; it cannot make re-exposure risk-free or replace alternative-agent selection and emergency readiness.
Route changes threshold
First-pass renal arterial exposure creates a different risk category from routine intravenous or second-pass exposure and changes metformin handling.
07Common pitfallsFrequent interpretation and management errors.
- 01
Waiting for renal blood tests when contrast CT is required to prevent immediate death or loss of treatment opportunity.
- 02
Calling every post-contrast creatinine rise contrast-induced without assessing sepsis, shock, obstruction and other nephrotoxins.
- 03
Withholding metformin from every patient regardless of eGFR, acute kidney injury and exposure route.
- 04
Reusing the known culprit agent without clarifying a previous moderate or severe hypersensitivity reaction.
- 05
Recording only contrast allergy and losing the product, phenotype, timing, severity and treatment details.